Office of the Director; Notice of Charter Renewal, 28571 [2023-09440]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 86 / Thursday, May 4, 2023 / Notices
Avenue, Bethesda, Maryland 20892 (Hybrid
Meeting).
Contact Person: Marc Rigas, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institutes of General
Medical Sciences, National Institute of
Health, 45 Center Drive, Room 3AN18C,
Bethesda, Maryland 20892, 301–827–0648,
marc.rigas@nih.gov.
Name of Committee: NIGMS Initial Review
Group Training and Workforce Development
Study Section–C; Review of G–RISE, IMSD,
and PREP Applications.
Date: June 15–16, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Bethesdan Hotel, Tapestry
Collection by Hilton, 8120 Wisconsin
Avenue, Bethesda, Maryland 20892 (Hybrid
Meeting).
Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Bethesda, Maryland 20892, 301–402–
9448, sonia.ortiz-miranda@nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nigms.nih.gov/, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: May 1, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09521 Filed 5–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
Office of the Director; Notice of Charter
Renewal
In accordance with title 41 of the U.S.
Code of Federal Regulations, section
102–3.65(a), notice is hereby given that
the Charter for the Center for Scientific
Review Advisory Council was renewed
for an additional two-year period on
March 31, 2023.
It is determined that the Center for
Scientific Review Advisory Council is
in the public interest in connection with
the performance of duties imposed on
the National Institutes of Health by law,
and that these duties can best be
performed through the advice and
counsel of this group.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
VerDate Sep<11>2014
17:12 May 03, 2023
Jkt 259001
28571
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or harriscl@mail.nih.gov.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 28, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
[FR Doc. 2023–09440 Filed 5–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence Study
Section.
Date: June 15–16, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKL1,
6705 Rockledge Drive, Bethesda, MD 20890
(Virtual Meeting).
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–H,
Bethesda, MD 20892, (301) 827–7969,
Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 28, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09438 Filed 5–3–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Clinical Trials
Review Study Section.
Date: June 22, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 1, 6705 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Keary A Cope, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–A,
Bethesda, MD 20892–7924, (301) 827–7912,
copeka@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 28, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09451 Filed 5–3–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting for the
Interdepartmental Substance Use
Disorders Coordinating Committee
(ISUDCC)
Substance Abuse and Mental
Health Services Administration
(SAMHSA), Department of Health and
Human Services (HHS).
AGENCY:
E:\FR\FM\04MYN1.SGM
04MYN1
]]>Agencies
[Federal Register Volume 88, Number 86 (Thursday, May 4, 2023)]
[Notices]
[Page 28571]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09440]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Charter Renewal
In accordance with title 41 of the U.S. Code of Federal
Regulations, section 102-3.65(a), notice is hereby given that the
Charter for the Center for Scientific Review Advisory Council was
renewed for an additional two-year period on March 31, 2023.
It is determined that the Center for Scientific Review Advisory
Council is in the public interest in connection with the performance of
duties imposed on the National Institutes of Health by law, and that
these duties can best be performed through the advice and counsel of
this group.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: April 28, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-09440 Filed 5-3-23; 8:45 am]
BILLING CODE 4140-01-P
